264 related articles for article (PubMed ID: 9710963)
1. Non-cancer risk assessment for nickel compounds: issues associated with dose-response modeling of inhalation and oral exposures.
Haber LT; Allen BC; Kimmel CA
Toxicol Sci; 1998 Jun; 43(2):213-29. PubMed ID: 9710963
[TBL] [Abstract][Full Text] [Related]
2. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
3. Health assessment of phosgene: approaches for derivation of reference concentration.
Gift JS; McGaughy R; Singh DV; Sonawane B
Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
Clewell HJ; Gentry PR; Gearhart JM
J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
[TBL] [Abstract][Full Text] [Related]
6. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
7. A procedure for developing risk-based reference doses.
Gaylor DW; Kodell RL
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
[TBL] [Abstract][Full Text] [Related]
10. Hazard identification and dose response of ingested nickel-soluble salts.
Haber LT; Diamond GL; Zhao Q; Erdreich L; Dourson ML
Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):231-41. PubMed ID: 10854128
[TBL] [Abstract][Full Text] [Related]
11. Derivation of noncancer reference values for acrylonitrile.
Kirman CR; Sweeney LM; Gargas ML; Strother DE; Collins JJ; Deskin R
Risk Anal; 2008 Oct; 28(5):1375-94. PubMed ID: 18761732
[TBL] [Abstract][Full Text] [Related]
12. Inhalation carcinogenicity study with nickel metal powder in Wistar rats.
Oller AR; Kirkpatrick DT; Radovsky A; Bates HK
Toxicol Appl Pharmacol; 2008 Dec; 233(2):262-75. PubMed ID: 18822311
[TBL] [Abstract][Full Text] [Related]
13. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
14. Use of benchmark dose and meta-analysis to determine the most sensitive endpoint for risk assessment for dimethoate.
Reiss R; Gaylor D
Regul Toxicol Pharmacol; 2005 Oct; 43(1):55-65. PubMed ID: 16099569
[TBL] [Abstract][Full Text] [Related]
15. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
Gentry PR; Covington TR; Clewell HJ; Anderson ME
J Toxicol Environ Health A; 2003 Dec; 66(23):2209-25. PubMed ID: 14612334
[TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
17. Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints.
Sand S; von Rosen D; Victorin K; Filipsson AF
Toxicol Sci; 2006 Mar; 90(1):241-51. PubMed ID: 16322076
[TBL] [Abstract][Full Text] [Related]
18. Hazard identification and dose response of inhaled nickel-soluble salts.
Haber LT; Erdreicht L; Diamond GL; Maier AM; Ratney R; Zhao Q; Dourson ML
Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):210-30. PubMed ID: 10854127
[TBL] [Abstract][Full Text] [Related]
19. Oral carcinogenicity study with nickel sulfate hexahydrate in Fischer 344 rats.
Heim KE; Bates HK; Rush RE; Oller AR
Toxicol Appl Pharmacol; 2007 Oct; 224(2):126-37. PubMed ID: 17692353
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
